What it means:
Our fetal imaging technologists, fetal radiologists and maternal fetal medicine doctors see thousands of images a year and focus only on prenatal (before birth) diagnoses. They have a trained eye that only experience can bring, which means you get the most accurate diagnosis.
Our twin-to-twin transfusion syndrome outcomes
Twin-to-twin transfusion syndrome (TTTS) is a serious and rare condition in identical twins who share a placenta. An imbalance in circulation of fluid and blood can create severe complications in twins. We treat the most severe and complex cases of TTTS that other fetal centers might not treat at all.
What we measure:
We track survival rates for one and both twins in TTTS pregnancies and our total selective fetoscopic laser photocoagulation (SFLP) procedures to repair TTTS. A number of factors impact survival, including severity of the condition, when it was diagnosed, risk of prematurity and the presence of selective fetal growth restriction.
64.9%
Survival for both twins since 2012 (higher than national benchmark)
411
SFLPs between 2012 and 2022
90.5%
Survival for at least one twin since 2012 (higher than national benchmark)
The following table shows our survival rates compared to the Solomon Group, an industry benchmark that we compare ourselves to. The Solomon Group was part of a clinical trial to establish expected outcomes for TTTS pregnancies that require SFLP, and advanced surgical treatment.
Twin-to-twin transfusion survival rates (Jan. 2012 to Dec. 2022)
|
Solomon Group |
Children's Colorado Group |
Overall survival |
74% |
76.2% |
At least one surviving neonate |
85% |
87.4% |
Double survival |
64% |
64.9% |
TAPS or recurring TTTS |
4% |
4.1% |
What it means:
We perform a high volume of SFLPs and higher volumes lead to better outcomes. When compared to the Solomon Group, the Colorado Fetal Care Center has higher survival rates for one or both twins. We achieve these survival rates even though we treat the most severe cases of TTTS.
Learn more about our TTTS outcomes and care
Our myelomeningocele outcomes
Myelomeningocele (MMC) is a serious form of spina bifida, a birth defect of the spine and spinal cord. MMC occurs when the baby’s spine, spinal cord and spinal canal don’t close properly. We often treat MMC with open fetal surgery or fetoscopic MMC repair, which can reduce the need for a shunt and improve movement for your baby.
What we measure:
We measure the shunt rate, which is how often a baby with MMC will need a shunt at some point to help drain excess spinal fluid from the brain. We measure shunt rate overall and by procedure type. A shunt increases the chances for further complications in the future, so the lower the rate the better. We compare our shunt rate to a national study (MOMS), in which the benchmark is 40%.
Our team also reports the total MMC surgeries we've performed since 2012.
38%
Shunt rate since 2012 (lower than national benchmark)
135+
MMC surgeries since 2012
ZERO
Shunts for babies who had fetoscopic MMC repair
What it means:
When compared to the outcomes of a national study on surgical repair of MMC, we have a a lower shunt rate thanks to our experienced team and multidisciplinary approach. This reduces the risk for future complications and means the baby doesn’t need a shunt placement operation.
Our total volume of surgeries illustrates that we have one of the most experienced surgery teams in the country for MMC repair. Higher volumes lead to better outcomes for babies and families with MMC.
Learn more about our MMC outcomes and care
Our congenital diaphragmatic hernia outcomes
Congenital diaphragmatic hernia (CDH) is a birth defect that occurs when a baby’s diaphragm doesn’t form correctly creating an opening between the chest and abdominal cavities. This allows abdominal organs to enter the chest cavity and prevent lung development.
We treat CDH both before and after birth depending on what is best for each baby.
What we measure:
We measure overall volume of patients with CDH, survival rate and percentage of patients who deliver their babies at Children’s Colorado when clinically necessary.